Cambrex announced that it is expanding its manufacturing center of excellence in High Point, NC.
Article continues below
The $30+ million investment is designed to meet the continually growing demand for small molecule development and manufacturing services.
The expansion will add new chemistry laboratories, two new clinical manufacturing suites and include a small scale commercial manufacturing operation with three work centers and 2,000 Litre reactors.
This investment will provide Cambrex with the capabilities to handle the latest R&D process research tools and techniques, increase Cambrex's equipment offerings to support customer's speed to market goals, and provide a dedicated facility for orphan drugs and niche therapies (annual volumes <500kg).
Alongside the new infrastructure which focuses on energy savings and efficiency, 78 new jobs will be created in the area. New positions include operations, scientists, quality assurance and administrative personnel.
A performance based grant of $200,000 from the One North Carolina Fund will help with Cambrex's expansion. The One North Carolina Fund provides financial assistance to local governments to help attract economic investment and to create jobs.
Cambrex is the leading small molecule company that provides drug substance, drug product, and analytical services across the entire drug lifecycle. The company provides customers with an end to end partnership for the research, development, and manufacture of small molecule therapeutics.
With over 40 years' experience and a growing team of over 2,200 experts servicing global clients from sites in North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and dosage form development and manufacturing.
Cambrex offers a range of specialist drug substance technologies and capabilities, including biocatalysis, continuous flow, controlled substances, solid state science, material characterization, and highly potent APIs.
In addition, Cambrex can support conventional dosage forms, including oral solids, semi solids, and liquids, and has the expertise to manufacture specialist dosage forms such as modified release, fixed dose combination, pediatric, bi layer tablets, stick packs, topicals, controlled substances, sterile and non sterile ointments. ■